Perrigo completes €305.6M sale of Dermacosmetics Business to Karo Healthcare

Filed April 30, 2026 · Period ending April 30, 2026 · ~1 min read

Key Changes

• high

  Perrigo received €305.6 million in cash at closing for its Dermacosmetics Business in Northern Europe, Netherlands and Poland, including €5.6 million in net working capital adjustments. Transaction closes strategic divestiture announced in July 2025.

  Item 1.01 view on EDGAR →
• medium

  Company may receive up to €27 million in additional earnout payments over three years if the divested business hits undisclosed performance targets, adding potential upside to the base purchase price.

  Item 1.01 view on EDGAR →
• low

  Original buyer Kairos Bidco AB (KKR-managed) assigned all rights to affiliate Karo Healthcare AB prior to closing. This structural change does not affect transaction terms or economics for Perrigo.

  Item 1.01 view on EDGAR →